{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:57:29Z","timestamp":1762955849514,"version":"3.37.3"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008900","name":"University of South Florida","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008900","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Addictive Behaviors"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.addbeh.2017.12.024","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T13:22:15Z","timestamp":1513862535000},"page":"159-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Nonmedical prescription drug use among African Americans who use MDMA (ecstasy\/molly): Implications for risk reduction"],"prefix":"10.1016","volume":"79","author":[{"given":"Khary K.","family":"Rigg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.addbeh.2017.12.024_bb0005","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1081\/JA-200052290","article-title":"Characteristics of ecstasy users in S\u00e3o Paulo, Brazil","volume":"40","author":"Almeida de","year":"2005","journal-title":"Substance Use & Misuse"},{"issue":"3","key":"10.1016\/j.addbeh.2017.12.024_bb0010","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1124\/jpet.302.3.898","article-title":"Changes in cardiovascular responsiveness and cardiotoxicity elicited during binge administration of ecstasy","volume":"302","author":"Badon","year":"2002","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"2","key":"10.1016\/j.addbeh.2017.12.024_bb0015","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.drugalcdep.2007.04.009","article-title":"Non-medical use, abuse and dependence on sedatives and tranquilizers among US adults: psychiatric and socio-demographic correlates","volume":"90","author":"Becker","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2017.12.024_bb0020","unstructured":"Bellum, S. (2013, April). Rap music and molly. Retrieved from: https:\/\/teens.drugabuse.gov\/blog\/post\/rap-music-and-molly."},{"issue":"2","key":"10.1016\/j.addbeh.2017.12.024_bb0025","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/002204260803800207","article-title":"Poly-drug use among ecstasy users: Separate, synergistic, and indiscriminate patterns","volume":"38","author":"Boeri","year":"2008","journal-title":"Journal of Drug Issues"},{"issue":"4","key":"10.1016\/j.addbeh.2017.12.024_bb0030","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1177\/002204260403400406","article-title":"Rolling beyond raves: Ecstasy use outside the rave setting","volume":"34","author":"Boeri","year":"2004","journal-title":"Journal of Drug Issues"},{"key":"10.1016\/j.addbeh.2017.12.024_bb0035","series-title":"21st Century research on drugs and ethnicity: Studies supported by the National Institute on Drug Abuse","first-page":"75","article-title":"Race\/ethnicity and gender differences in drug use and abuse among college students","volume":"6(2)","author":"Boyd","year":"2014"},{"issue":"6","key":"10.1016\/j.addbeh.2017.12.024_bb0040","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1542\/peds.2006-1644","article-title":"Adolescents' motivations to abuse prescription medications","volume":"118","author":"Boyd","year":"2006","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.addbeh.2017.12.024_bb0045","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s10900-012-9582-8","article-title":"Substance use and sexual risk mediated by social support among black men","volume":"38","author":"Buttram","year":"2013","journal-title":"Journal of Community Health"},{"year":"2015","series-title":"2014 National Survey on Drug Use and Health: Methodological summary and definitions","author":"Center for Behavioral Health Statistics and Quality","key":"10.1016\/j.addbeh.2017.12.024_bb0050"},{"key":"10.1016\/j.addbeh.2017.12.024_bb0055","series-title":"Handbook of qualitative research","first-page":"509","article-title":"Grounded theory: Objectivist and constructivist methods","author":"Charmaz","year":"2000"},{"key":"10.1016\/j.addbeh.2017.12.024_bb0060","series-title":"Inside interviewing: New lenses, new concerns","first-page":"311","article-title":"Qualitative interviewing and grounded theory analysis","author":"Charmaz","year":"2003"},{"author":"Chodosh","key":"10.1016\/j.addbeh.2017.12.024_bb0065"},{"year":"2010","series-title":"Reliability of key measures in the National Survey on Drug Use and Health (HHS publication no. SMA 09\u20134425, methodology series M-8)","author":"Chromy","key":"10.1016\/j.addbeh.2017.12.024_bb0070"},{"key":"10.1016\/j.addbeh.2017.12.024_bb0075","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/0006-3223(95)00551-X","article-title":"Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; \u2018ecstasy\u2019)","volume":"39","author":"Cohen","year":"1996","journal-title":"Biological Psychiatry"},{"author":"Community Epidemiology Work Group","key":"10.1016\/j.addbeh.2017.12.024_bb0080"},{"issue":"2","key":"10.1016\/j.addbeh.2017.12.024_bb0085","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.addbeh.2005.05.025","article-title":"Ecstasy and the concomitant use of pharmaceuticals","volume":"31","author":"Copeland","year":"2006","journal-title":"Addictive Behaviors"},{"issue":"7","key":"10.1016\/j.addbeh.2017.12.024_bb0090","first-page":"821","article-title":"Mood and cognitive effects of \u00b13, 4- methylenedioxymethamphetamine (MDMA,\u2018ecstasy\u2019): Week-end \u2018high\u2019 followed by mid-week low","volume":"92","author":"Curran","year":"1997","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.addbeh.2017.12.024_bb0095","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMsa1406143","article-title":"Trends in opioid analgesic abuse and mortality in the United States","volume":"372","author":"Dart","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.addbeh.2017.12.024_bb0100","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/0743558406287398","article-title":"What\u2019s the Rap About Ecstasy? Popular Music Lyrics and Drug Trends Among American Youth","volume":"21","author":"Diamond","year":"2006","journal-title":"Journal of Adolescent Research"},{"issue":"12","key":"10.1016\/j.addbeh.2017.12.024_bb0105","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.1987.03390120077027","article-title":"\u2018Eve'and'ecstasy\u2019: A report of five deaths associated with the use of MDEA and MDMA","volume":"257","author":"Dowling","year":"1987","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.addbeh.2017.12.024_bb0110","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/01.ajp.0000210926.41406.2c","article-title":"Potential influences on initiation and persistence of extramedical prescription pain reliever use in the US population","volume":"22","author":"Dowling","year":"2006","journal-title":"The Clinical Journal of Pain"},{"issue":"9","key":"10.1016\/j.addbeh.2017.12.024_bb0115","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.1360-0443.2006.01511.x","article-title":"The origin of MDMA (ecstasy) revisited: The true story reconstructed from the original documents","volume":"101","author":"Freudenmann","year":"2006","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.addbeh.2017.12.024_bb0120","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s11121-014-0514-y","article-title":"Racial\/ethnic differences in factors that place adolescents at risk for prescription opioid misuse","volume":"16","author":"Ford","year":"2015","journal-title":"Prevention Science"},{"issue":"5","key":"10.1016\/j.addbeh.2017.12.024_bb0125","first-page":"583","article-title":"Combination of heroin and ecstasy with fatal outcome","volume":"15","author":"Gerevich","year":"2000","journal-title":"Psychiatria Hungarica"},{"issue":"1","key":"10.1016\/j.addbeh.2017.12.024_bb0130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1365-2125.2002.01574.x","article-title":"CYP2D6 deficiency, a factor in ecstasy related deaths?","volume":"54","author":"Gilhooly","year":"2002","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1016\/j.addbeh.2017.12.024_bb0135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1520\/JFS15211J","article-title":"Ecstasy (MDMA) deaths in New York City: A case series and review of the literature","volume":"47","author":"Gill","year":"2002","journal-title":"Journal of Forensic Science"},{"issue":"1","key":"10.1016\/j.addbeh.2017.12.024_bb0140","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1196\/annals.1369.035","article-title":"MDMA and seizures: A dangerous liaison?","volume":"1074","author":"Giorgi","year":"2006","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"3","key":"10.1016\/j.addbeh.2017.12.024_bb0145","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.drugalcdep.2009.05.017","article-title":"Racial\/ethnic differences in correlates of prescription drug misuse among young adults","volume":"104","author":"Harrell","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.addbeh.2017.12.024_bb0150","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jadohealth.2006.01.006","article-title":"Risk and protective factors for nonmedical use of prescription stimulants and methamphetamine among adolescents","volume":"39","author":"Herman-Stahl","year":"2006","journal-title":"Journal of Adolescent Health"},{"issue":"7","key":"10.1016\/j.addbeh.2017.12.024_bb0155","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1360-0443.2007.01847.x","article-title":"Crystal methamphetamine use among young adults in the USA","volume":"102","author":"Iritani","year":"2007","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.addbeh.2017.12.024_bb0160","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/13645570600659433","article-title":"Software and method: Reflections on teaching and using QSR NVivo in doctoral research","volume":"9","author":"Johnston","year":"2006","journal-title":"International Journal of Social Research Methodology"},{"year":"2014","series-title":"Demographic subgroup trends\u00a0among adolescents in the use of various licit and illicit drugs,\u00a01975\u20132016 (Monitoring the Future Occasional Paper No. 88)","author":"Johnston","key":"10.1016\/j.addbeh.2017.12.024_bb0165"},{"issue":"7","key":"10.1016\/j.addbeh.2017.12.024_bb0170","first-page":"917","article-title":"The pharmacology and toxicology of \u201cecstasy\u201d(MDMA) and related drugs","volume":"165","author":"Kalant","year":"2001","journal-title":"Canadian Medical Association Journal"},{"key":"10.1016\/j.addbeh.2017.12.024_bb0175","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.drugalcdep.2017.05.047","article-title":"Increases from 2002 to 2015 in prescription opioid overdose deaths in combination with other substances","volume":"178","author":"Kandel","year":"2017","journal-title":"Drug & Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.addbeh.2017.12.024_bb0180","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0376-8716(01)00189-2","article-title":"MDMA (\u2018ecstasy\u2019) use, and its association with high risk behaviors, mental health, and other factors among gay\/bisexual men in New York City","volume":"66","author":"Klitzman","year":"2002","journal-title":"Drug and Alcohol Dependence"},{"issue":"7","key":"10.1016\/j.addbeh.2017.12.024_bb0185","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1176\/appi.ajp.157.7.1162","article-title":"MDMA (\u201cEcstasy\u201d) abuse and high-risk sexual behaviors among 169 gay and bisexual men","volume":"157","author":"Klitzman","year":"2000","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1016\/j.addbeh.2017.12.024_bb0190","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/cpt.565","article-title":"Potential psychiatric uses for MDMA","volume":"101","author":"Klosinski","year":"2017","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"2","key":"10.1016\/j.addbeh.2017.12.024_bb0195","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drugalcdep.2005.12.011","article-title":"Nonmedical use of prescription stimulants in the United States","volume":"84","author":"Kroutil","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.addbeh.2017.12.024_bb0200","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/02791072.2016.1269978","article-title":"Benzodiazepine dependence among young adult participants in the club scene who use drugs","volume":"49","author":"Kurtz","year":"2017","journal-title":"Journal of Psychoactive Drugs"},{"issue":"4","key":"10.1016\/j.addbeh.2017.12.024_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1300\/J069v24n04_01","article-title":"Prescription drug abuse among ecstasy users in Miami","volume":"24","author":"Kurtz","year":"2006","journal-title":"Journal of Addictive Diseases"},{"issue":"4","key":"10.1016\/j.addbeh.2017.12.024_bb0210","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/0269881103174015","article-title":"Dissociable effects of a single dose of ecstasy (MDMA) on psychomotor skills and attentional performance","volume":"17","author":"Lamers","year":"2003","journal-title":"Journal of Psychopharmacology"},{"year":"1995","series-title":"Analyzing social settings: A guide to qualitative observation and analysis","author":"Lofland","key":"10.1016\/j.addbeh.2017.12.024_bb0215"},{"issue":"1","key":"10.1016\/j.addbeh.2017.12.024_bb0220","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.drugalcdep.2004.12.006","article-title":"Correlates of nonmedical use of prescription benzodiazepine anxiolytics: Results from a national survey of US college students","volume":"79","author":"McCabe","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"issue":"10","key":"10.1016\/j.addbeh.2017.12.024_bb0225","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.addbeh.2008.06.005","article-title":"Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: Results from two national surveys","volume":"33","author":"McCabe","year":"2008","journal-title":"Addictive Behaviors"},{"issue":"4","key":"10.1016\/j.addbeh.2017.12.024_bb0230","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.pbb.2011.06.032","article-title":"MDMA: interactions with other psychoactive drugs","volume":"99","author":"Mohamed","year":"2011","journal-title":"Pharmacology Biochemistry and Behavior"},{"issue":"4","key":"10.1016\/j.addbeh.2017.12.024_bb0235","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1080\/10673220216223","article-title":"Long-term neuropsychiatric consequences of\" ecstasy\"(MDMA): A review","volume":"10","author":"Montoya","year":"2002","journal-title":"Harvard Review of Psychiatry"},{"key":"10.1016\/j.addbeh.2017.12.024_bb0240","series-title":"MDMA\/ecstasy research conference, Bethesda, MD","article-title":"MDMA in combination: \u201cTrail mix\u201d and other powdered drug combinations","author":"Narvaez","year":"2001"},{"year":"2006","series-title":"Research report series: MDMA (ecstasy) abuse","author":"National Institute on Drug Abuse [NIDA]","key":"10.1016\/j.addbeh.2017.12.024_bb0245"},{"issue":"1","key":"10.1016\/j.addbeh.2017.12.024_bb0250","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1176\/appi.psy.45.1.84","article-title":"Ecstasy: Pharmacodynamic and pharmacokinetic interactions","volume":"45","author":"Oesterheld","year":"2004","journal-title":"Psychosomatics"},{"key":"10.1016\/j.addbeh.2017.12.024_bb0255","first-page":"2013","author":"Ouellet","year":"2014","journal-title":"Patterns and trends of drug abuse in Chicago"},{"issue":"13","key":"10.1016\/j.addbeh.2017.12.024_bb0260","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.3109\/10826084.2014.926933","article-title":"An examination of sociodemographic correlates of ecstasy use among high school seniors in the United States","volume":"49","author":"Palamar","year":"2014","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.addbeh.2017.12.024_bb0265","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.drugalcdep.2017.09.011","article-title":"Shifting characteristics of ecstasy users ages 12\u201334 in the United States, 2007\u20132014","volume":"181","author":"Palamar","year":"2017","journal-title":"Drug & Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.addbeh.2017.12.024_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2011.08.012","article-title":"MDMA and temperature: A review of the thermal effects of \u2018Ecstasy\u2019 in humans","volume":"121","author":"Parrott","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.addbeh.2017.12.024_bb0275","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/anatox\/35.4.219","article-title":"Deaths involving MDMA and the concomitant use of pharmaceutical drugs","volume":"35","author":"Pilgrim","year":"2011","journal-title":"Journal of Analytical Toxicology"},{"issue":"3","key":"10.1016\/j.addbeh.2017.12.024_bb0280","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/02791072.2017.1305518","article-title":"Motivations for using MDMA (ecstasy\/molly) among African Americans: Implications for prevention and harm-reduction programs","volume":"49","author":"Rigg","year":"2017","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/j.addbeh.2017.12.024_bb0285","first-page":"1","article-title":"MDMA (ecstasy\/molly) use among African Americans: Patterns of initiation","author":"Rigg","year":"2017","journal-title":"International Journal of Mental Health and Addiction"},{"key":"10.1016\/j.addbeh.2017.12.024_bb0290","first-page":"1","article-title":"Perceived risk associated with MDMA (ecstasy\/molly) use among African Americans: What prevention and treatment providers should know","author":"Rigg","year":"2017","journal-title":"Substance Use & Misuse"},{"issue":"3\u20134","key":"10.1016\/j.addbeh.2017.12.024_bb0295","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00213-003-1730-5","article-title":"A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities","volume":"173","author":"Schifano","year":"2004","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.addbeh.2017.12.024_bb0300","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1177\/0269881106060147","article-title":"Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994\u20132003)","volume":"20","author":"Schifano","year":"2005","journal-title":"Journal of Psychopharmacology"},{"issue":"7","key":"10.1016\/j.addbeh.2017.12.024_bb0305","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/hup.528","article-title":"Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996\u20132002","volume":"18","author":"Schifano","year":"2003","journal-title":"Human Psychopharmacology: Clinical and Experimental"},{"issue":"4","key":"10.1016\/j.addbeh.2017.12.024_bb0310","article-title":"Patterns and harms of pharmaceutical drug use among ecstasy users in Australia","volume":"21","author":"Silins","year":"2009","journal-title":"Adicciones"},{"issue":"2","key":"10.1016\/j.addbeh.2017.12.024_bb0315","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2105\/AJPH.94.2.266","article-title":"Risk factors associated with problem use of prescription drugs","volume":"94","author":"Simoni-Wastila","year":"2004","journal-title":"American Journal of Public Health"},{"issue":"3","key":"10.1016\/j.addbeh.2017.12.024_bb0320","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.drugalcdep.2003.12.015","article-title":"Psychosocial profiles of older adolescent MDMA users","volume":"74","author":"Singer","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.addbeh.2017.12.024_bb0325","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1108\/17459265200900004","article-title":"MDMA powder, pills and crystal: The persistence of ecstasy and the poverty of policy","volume":"9","author":"Smith","year":"2009","journal-title":"Drugs and Alcohol Today"},{"year":"2013","series-title":"Qualtrics survey software: Handbook for research professionals","author":"Snow","key":"10.1016\/j.addbeh.2017.12.024_bb0330"},{"issue":"8","key":"10.1016\/j.addbeh.2017.12.024_bb0335","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/hup.350","article-title":"Psychiatric disorders in Ecstasy (MDMA) users: A literature review focusing on personal predisposition and drug history","volume":"16","author":"Soar","year":"2001","journal-title":"Human Psychopharmacology: Clinical and Experimental"},{"issue":"5","key":"10.1016\/j.addbeh.2017.12.024_bb0340","doi-asserted-by":"crossref","first-page":"231","DOI":"10.9740\/mhc.n207181","article-title":"Have you seen Molly? A review of molly in primary literature","volume":"4","author":"Steinhardt","year":"2014","journal-title":"Mental Health Clinician"},{"issue":"1","key":"10.1016\/j.addbeh.2017.12.024_bb0345","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1054-139X(01)00315-9","article-title":"Increasing MDMA use among college students: Results of a national survey","volume":"30","author":"Strote","year":"2002","journal-title":"Journal of Adolescent Health"},{"year":"2005","series-title":"Results from the 2004 National Survey on Drug Use and Health: National findings","author":"Substance Abuse and Mental Health Services Administration [SAMHSA]","key":"10.1016\/j.addbeh.2017.12.024_bb0350"},{"year":"2015","series-title":"National Survey on Drug Use and Health, 2002\u20132014","author":"Substance Abuse and Mental Health Services Administration [SAMHSA]","key":"10.1016\/j.addbeh.2017.12.024_bb0355"},{"key":"10.1016\/j.addbeh.2017.12.024_bb0360","series-title":"Alcohol involvement remains a concern","article-title":"Ecstasy-related emergency department visits by young people increased between 2005 and 2011","author":"Substance Abuse and Mental Health Services Administration [SAMHSA]","year":"2013"},{"issue":"1","key":"10.1016\/j.addbeh.2017.12.024_bb0365","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/02791072.2001.10400473","article-title":"An \u201caccidental\u201d acute psychosis with ecstasy use","volume":"33","author":"Vaiva","year":"2001","journal-title":"Journal of Psychoactive Drugs"},{"issue":"3","key":"10.1016\/j.addbeh.2017.12.024_bb0370","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1360-0443.2003.00292.x","article-title":"Death following ingestion of MDMA (ecstasy) and moclobemide","volume":"98","author":"Vuori","year":"2003","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.addbeh.2017.12.024_bb0375","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2190\/RJX5-WRA6-BNG5-Q2TY","article-title":"It's a rave new world: Estimating the prevalence and perceived harm of ecstasy and other drug use among club rave attendees","volume":"33","author":"Yacoubian","year":"2003","journal-title":"Journal of Drug Education"}],"container-title":["Addictive Behaviors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460317304793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460317304793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T18:48:47Z","timestamp":1536173327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306460317304793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":75,"alternative-id":["S0306460317304793"],"URL":"https:\/\/doi.org\/10.1016\/j.addbeh.2017.12.024","relation":{},"ISSN":["0306-4603"],"issn-type":[{"type":"print","value":"0306-4603"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonmedical prescription drug use among African Americans who use MDMA (ecstasy\/molly): Implications for risk reduction","name":"articletitle","label":"Article Title"},{"value":"Addictive Behaviors","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addbeh.2017.12.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}